This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cannon, P. M. Articles by Kingsman, A. J. Search for Related Content PubMed PubMed Citation Articles by Cannon, P. M. Articles by Kingsman, A. J.

 Previous Article  |  Next Article 

J. Virol., May 1997, 3474-3483, Vol 71, No. 5
Copyright © 1997, American Society for Microbiology

Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17

PM Cannon, S Matthews, N Clark, ED Byles, O Iourin, DJ Hockley, SM Kingsman and AJ Kingsman
Department of Biochemistry, University of Oxford, United Kingdom.

The human immunodeficiency virus type 1 (HIV-1) matrix protein, p17, plays important roles in both the early and late stages of the viral life cycle. Using our previously determined solution structure of p17, we have undertaken a rational mutagenesis program aimed at mapping structure-function relationships within the molecule. Amino acids hypothesized to be important for p17 function were mutated and examined for effect in an infectious proviral clone of HIV-1. In parallel, we analyzed by nuclear magnetic resonance spectroscopy the structure of recombinant p17 protein containing such substitutions. These analyses identified three classes of mutants that were defective in viral replication: (i) proteins containing substitutions at internal residues that grossly distorted the structure of recombinant p17 and prevented viral particle formation, (ii) mutations at putative p17 trimer interfaces that allowed correct folding of recombinant protein but produced virus that was defective in particle assembly, and (iii) substitution of basic residues in helix A that caused some relocation of virus assembly to intracellular locations and produced normally budded virions that were completely noninfectious.

This article has been cited by other articles:

• Vlach, J., Lipov, J., Rumlova, M., Veverka, V., Lang, J., Srb, P., Knejzlik, Z., Pichova, I., Hunter, E., Hrabal, R., Ruml, T. (2008). D-retrovirus morphogenetic switch driven by the targeting signal accessibility to Tctex-1 of dynein. Proc. Natl. Acad. Sci. USA 105: 10565-10570 [Abstract] [Full Text]  
• Joseph, A., Zheng, J. H., Follenzi, A., DiLorenzo, T., Sango, K., Hyman, J., Chen, K., Piechocka-Trocha, A., Brander, C., Hooijberg, E., Vignali, D. A., Walker, B. D., Goldstein, H. (2008). Lentiviral Vectors Encoding Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Receptor Genes Efficiently Convert Peripheral Blood CD8 T Lymphocytes into Cytotoxic T Lymphocytes with Potent In Vitro and In Vivo HIV-1-Specific Inhibitory Activity. J. Virol. 82: 3078-3089 [Abstract] [Full Text]  
• Hamano, T., Matsuo, K., Hibi, Y., Victoriano, A. F. B., Takahashi, N., Mabuchi, Y., Soji, T., Irie, S., Sawanpanyalert, P., Yanai, H., Hara, T., Yamazaki, S., Yamamoto, N., Okamoto, T. (2007). A Single-Nucleotide Synonymous Mutation in the gag Gene Controlling Human Immunodeficiency Virus Type 1 Virion Production. J. Virol. 81: 1528-1533 [Abstract] [Full Text]  
• Saad, J. S., Miller, J., Tai, J., Kim, A., Ghanam, R. H., Summers, M. F. (2006). From the Cover: Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. USA 103: 11364-11369 [Abstract] [Full Text]  
• Kan-Mitchell, J., Bajcz, M., Schaubert, K. L., Price, D. A., Brenchley, J. M., Asher, T. E., Douek, D. C., Ng, H. L., Yang, O. O., Rinaldo, C. R. Jr., Benito, J. M., Bisikirska, B., Hegde, R., Marincola, F. M., Boggiano, C., Wilson, D., Abrams, J., Blondelle, S. E., Wilson, D. B. (2006). Degeneracy and Repertoire of the Human HIV-1 Gag p1777-85 CTL Response.. J. Immunol. 176: 6690-6701 [Abstract] [Full Text]  
• Dalton, A. K., Murray, P. S., Murray, D., Vogt, V. M. (2005). Biochemical Characterization of Rous Sarcoma Virus MA Protein Interaction with Membranes. J. Virol. 79: 6227-6238 [Abstract] [Full Text]  
• Ono, A., Ablan, S. D., Lockett, S. J., Nagashima, K., Freed, E. O. (2004). Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. USA 101: 14889-14894 [Abstract] [Full Text]  
• Wu, Z., Alexandratos, J., Ericksen, B., Lubkowski, J., Gallo, R. C., Lu, W. (2004). Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: Structural and mechanistic implications of p17 myristoylation. Proc. Natl. Acad. Sci. USA 101: 11587-11592 [Abstract] [Full Text]  
• Kan-Mitchell, J., Bisikirska, B., Wong-Staal, F., Schaubert, K. L., Bajcz, M., Bereta, M. (2004). The HIV-1 HLA-A2-SLYNTVATL Is a Help-Independent CTL Epitope. J. Immunol. 172: 5249-5261 [Abstract] [Full Text]  
• Ono, A., Orenstein, J. M., Freed, E. O. (2000). Role of the Gag Matrix Domain in Targeting Human Immunodeficiency Virus Type 1 Assembly. J. Virol. 74: 2855-2866 [Abstract] [Full Text]  
• Parent, L. J., Cairns, T. M., Albert, J. A., Wilson, C. B., Wills, J. W., Craven, R. C. (2000). RNA Dimerization Defect in a Rous Sarcoma Virus Matrix Mutant. J. Virol. 74: 164-172 [Abstract] [Full Text]  
• Brander, C., Yang, O. O., Jones, N. G., Lee, Y., Goulder, P., Johnson, R. P., Trocha, A., Colbert, D., Hay, C., Buchbinder, S., Bergmann, C. C., Zweerink, H. J., Wolinsky, S., Blattner, W. A., Kalams, S. A., Walker, B. D. (1999). Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flanking Sequences. J. Virol. 73: 10191-10198 [Abstract] [Full Text]  
• Choi, G., Park, S., Choi, B., Hong, S., Lee, J., Hunter, E., Rhee, S. S. (1999). Identification of a Cytoplasmic Targeting/Retention Signal in a Retroviral Gag Polyprotein. J. Virol. 73: 5431-5437 [Abstract] [Full Text]  
• Kiernan, R. E., Ono, A., Freed, E. O. (1999). Reversion of a Human Immunodeficiency Virus Type 1 Matrix Mutation Affecting Gag Membrane Binding, Endogenous Reverse Transcriptase Activity, and Virus Infectivity. J. Virol. 73: 4728-4737 [Abstract] [Full Text]  
• Paillart, J.-C., Göttlinger, H. G. (1999). Opposing Effects of Human Immunodeficiency Virus Type 1 Matrix Mutations Support a Myristyl Switch Model of Gag Membrane Targeting. J. Virol. 73: 2604-2612 [Abstract] [Full Text]  
• Simon, J. H. M., Carpenter, E. A., Fouchier, R. A. M., Malim, M. H. (1999). Vif and the p55Gag Polyprotein of Human Immunodeficiency Virus Type 1 Are Present in Colocalizing Membrane-Free Cytoplasmic Complexes. J. Virol. 73: 2667-2674 [Abstract] [Full Text]  
• Peytavi, R., Hong, S. S., Gay, B., d'Angeac, A. D., Selig, L., Benichou, S., Benarous, R., Boulanger, P. (1999). HEED, the Product of the Human Homolog of the Murine eed Gene, Binds to the Matrix Protein of HIV-1. J. Biol. Chem. 274: 1635-1645 [Abstract] [Full Text]  
• Morikawa, Y., Zhang, W.-H., Hockley, D. J., Nermut, M. V., Jones, I. M. (1998). Detection of a Trimeric Human Immunodeficiency Virus Type 1 Gag Intermediate Is Dependent on Sequences in the Matrix Protein, p17. J. Virol. 72: 7659-7663 [Abstract] [Full Text]